New Gonorrhoea Treatment Shows Positive Results in Trial Sponsored by Non-Profit Partnership 02/11/2023 Kerry Cullinan The world may soon have a new antibiotic to treat gonorrhoea after a successful phase 3 trial of an oral pill, zoliflodacin, that was led and sponsored by a non-profit organisation. The results were announced late Wednesday by the Global Antibiotic Research and Development Partnership (GARDP), which conducted the trial in collaboration with Innoviva Specialty […] Continue reading -> ‘Future-proofing’ the Global Health Workforce to Address Chronic Diseases 24/10/2023 Elaine Ruth Fletcher Better access to NCD medicines and treatments isn’t enough to ensure effective prevention and treatment of the conditions, responsible for 74% of premature deaths in the world. More attention needs to be focused on training, retention and effective use of health care workers, said a panel of experts at the World Health Summit. BERLIN – […] Continue reading -> Getting Global Health on the Radar of Private Sector Investors and Asset Managers 13/10/2023 Elaine Ruth Fletcher In the wake of the COVID pandemic, global health is finally getting on the radar of asset managers of large equity and investment funds – as an option for promoting social responsibility objectives among investor clientele. At a Geneva Graduate Institute session Wednesday on Investors and Civil Society Working Together, two path-finding institutions – one […] Continue reading -> Health AI: Geneva Initiative Launches Global Agency to Support Artificial Intelligence Regulation 06/10/2023 Elaine Ruth Fletcher GENEVA – At the 1853 World Fair, the inventor of a new safety brake technology for elevators, Elisha Otis, demonstrated his innovation by posing an elevator right over the heads of a crowd of visitors and then cutting the cables. The new security brake kicked in. His gimmick helped build trust in an innovation that […] Continue reading -> Strengthening Africa’s Medicines Regulatory Framework is ‘Essential’ for Local Vaccine Production 13/09/2023 Kerry Cullinan Strengthening Africa’s medicines regulatory framework is key to achieving the “bold goal” of having 60% of the continent’s vaccines produced locally by 2040, said Margareth Ndomondo-Sigonda, head of health at the African Union’s development agency, AUDA-NEPAD. But only 7% of African country’s national medicines regulatory agencies (NMRA) have “moderately developed capacity”, and more than 90% […] Continue reading -> UN Draft Pandemic Declaration Offers ‘Little Hope’ for Strengthening Global Preparedness 01/09/2023 Stefan Anderson A draft political declaration on pandemics, due to be adopted by the United Nations General Assembly later this month, offers “little hope” that the UN process will make a difference in global pandemic preparedness, global health experts said on Friday. The document, made public on Thursday, is long on words but short on commitments. The […] Continue reading -> WHO Secures First COVID-19 Vaccine Licence from Private Pharmaceutical Company 31/08/2023 Stefan Anderson Three years after the launch of its COVID-19 Technology Access Pool (C-TAP) initiative, the World Health Organization (WHO) has secured its first COVID-19 vaccine license from a private pharmaceutical company, the UN health body announced on Tuesday. The agreement with Medigen Vaccine Biologics Corp., a private vaccine manufacturer based in Taiwan, is a welcome but underwhelming […] Continue reading -> Africa’s Cardiovascular Burden: A Silent Cry for Attention 23/08/2023 Ahmed Bendary & Abdelrahman Abushouk Amidst the vibrant rhythms of Africa, a less audible rhythm beats – an alarming rise in cardiovascular diseases (CVDs) and non-communicable diseases (NCDs). Between 50% and 88% of deaths in at least seven African countries are due to NCDs, according to the 2022 World Health Organization (WHO) Noncommunicable Disease Progress Monitor. Yet, the realm of […] Continue reading -> Brazil’s Success in Preventing Malaria Relapse Using New Single-Dose Treatment 20/07/2023 Marcus Lacerda & Elodie Jambert Brazil is the first country in the world to introduce tafenoquine, the first new single-dose treatment for P. vivax malaria developed in 70 years, in its public health system. Raquel da Silva has lived in Manaus in Brazil’s Amazonas State since her childhood. Today she shares her home on the banks of the Rio Negro […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
‘Future-proofing’ the Global Health Workforce to Address Chronic Diseases 24/10/2023 Elaine Ruth Fletcher Better access to NCD medicines and treatments isn’t enough to ensure effective prevention and treatment of the conditions, responsible for 74% of premature deaths in the world. More attention needs to be focused on training, retention and effective use of health care workers, said a panel of experts at the World Health Summit. BERLIN – […] Continue reading -> Getting Global Health on the Radar of Private Sector Investors and Asset Managers 13/10/2023 Elaine Ruth Fletcher In the wake of the COVID pandemic, global health is finally getting on the radar of asset managers of large equity and investment funds – as an option for promoting social responsibility objectives among investor clientele. At a Geneva Graduate Institute session Wednesday on Investors and Civil Society Working Together, two path-finding institutions – one […] Continue reading -> Health AI: Geneva Initiative Launches Global Agency to Support Artificial Intelligence Regulation 06/10/2023 Elaine Ruth Fletcher GENEVA – At the 1853 World Fair, the inventor of a new safety brake technology for elevators, Elisha Otis, demonstrated his innovation by posing an elevator right over the heads of a crowd of visitors and then cutting the cables. The new security brake kicked in. His gimmick helped build trust in an innovation that […] Continue reading -> Strengthening Africa’s Medicines Regulatory Framework is ‘Essential’ for Local Vaccine Production 13/09/2023 Kerry Cullinan Strengthening Africa’s medicines regulatory framework is key to achieving the “bold goal” of having 60% of the continent’s vaccines produced locally by 2040, said Margareth Ndomondo-Sigonda, head of health at the African Union’s development agency, AUDA-NEPAD. But only 7% of African country’s national medicines regulatory agencies (NMRA) have “moderately developed capacity”, and more than 90% […] Continue reading -> UN Draft Pandemic Declaration Offers ‘Little Hope’ for Strengthening Global Preparedness 01/09/2023 Stefan Anderson A draft political declaration on pandemics, due to be adopted by the United Nations General Assembly later this month, offers “little hope” that the UN process will make a difference in global pandemic preparedness, global health experts said on Friday. The document, made public on Thursday, is long on words but short on commitments. The […] Continue reading -> WHO Secures First COVID-19 Vaccine Licence from Private Pharmaceutical Company 31/08/2023 Stefan Anderson Three years after the launch of its COVID-19 Technology Access Pool (C-TAP) initiative, the World Health Organization (WHO) has secured its first COVID-19 vaccine license from a private pharmaceutical company, the UN health body announced on Tuesday. The agreement with Medigen Vaccine Biologics Corp., a private vaccine manufacturer based in Taiwan, is a welcome but underwhelming […] Continue reading -> Africa’s Cardiovascular Burden: A Silent Cry for Attention 23/08/2023 Ahmed Bendary & Abdelrahman Abushouk Amidst the vibrant rhythms of Africa, a less audible rhythm beats – an alarming rise in cardiovascular diseases (CVDs) and non-communicable diseases (NCDs). Between 50% and 88% of deaths in at least seven African countries are due to NCDs, according to the 2022 World Health Organization (WHO) Noncommunicable Disease Progress Monitor. Yet, the realm of […] Continue reading -> Brazil’s Success in Preventing Malaria Relapse Using New Single-Dose Treatment 20/07/2023 Marcus Lacerda & Elodie Jambert Brazil is the first country in the world to introduce tafenoquine, the first new single-dose treatment for P. vivax malaria developed in 70 years, in its public health system. Raquel da Silva has lived in Manaus in Brazil’s Amazonas State since her childhood. Today she shares her home on the banks of the Rio Negro […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Getting Global Health on the Radar of Private Sector Investors and Asset Managers 13/10/2023 Elaine Ruth Fletcher In the wake of the COVID pandemic, global health is finally getting on the radar of asset managers of large equity and investment funds – as an option for promoting social responsibility objectives among investor clientele. At a Geneva Graduate Institute session Wednesday on Investors and Civil Society Working Together, two path-finding institutions – one […] Continue reading -> Health AI: Geneva Initiative Launches Global Agency to Support Artificial Intelligence Regulation 06/10/2023 Elaine Ruth Fletcher GENEVA – At the 1853 World Fair, the inventor of a new safety brake technology for elevators, Elisha Otis, demonstrated his innovation by posing an elevator right over the heads of a crowd of visitors and then cutting the cables. The new security brake kicked in. His gimmick helped build trust in an innovation that […] Continue reading -> Strengthening Africa’s Medicines Regulatory Framework is ‘Essential’ for Local Vaccine Production 13/09/2023 Kerry Cullinan Strengthening Africa’s medicines regulatory framework is key to achieving the “bold goal” of having 60% of the continent’s vaccines produced locally by 2040, said Margareth Ndomondo-Sigonda, head of health at the African Union’s development agency, AUDA-NEPAD. But only 7% of African country’s national medicines regulatory agencies (NMRA) have “moderately developed capacity”, and more than 90% […] Continue reading -> UN Draft Pandemic Declaration Offers ‘Little Hope’ for Strengthening Global Preparedness 01/09/2023 Stefan Anderson A draft political declaration on pandemics, due to be adopted by the United Nations General Assembly later this month, offers “little hope” that the UN process will make a difference in global pandemic preparedness, global health experts said on Friday. The document, made public on Thursday, is long on words but short on commitments. The […] Continue reading -> WHO Secures First COVID-19 Vaccine Licence from Private Pharmaceutical Company 31/08/2023 Stefan Anderson Three years after the launch of its COVID-19 Technology Access Pool (C-TAP) initiative, the World Health Organization (WHO) has secured its first COVID-19 vaccine license from a private pharmaceutical company, the UN health body announced on Tuesday. The agreement with Medigen Vaccine Biologics Corp., a private vaccine manufacturer based in Taiwan, is a welcome but underwhelming […] Continue reading -> Africa’s Cardiovascular Burden: A Silent Cry for Attention 23/08/2023 Ahmed Bendary & Abdelrahman Abushouk Amidst the vibrant rhythms of Africa, a less audible rhythm beats – an alarming rise in cardiovascular diseases (CVDs) and non-communicable diseases (NCDs). Between 50% and 88% of deaths in at least seven African countries are due to NCDs, according to the 2022 World Health Organization (WHO) Noncommunicable Disease Progress Monitor. Yet, the realm of […] Continue reading -> Brazil’s Success in Preventing Malaria Relapse Using New Single-Dose Treatment 20/07/2023 Marcus Lacerda & Elodie Jambert Brazil is the first country in the world to introduce tafenoquine, the first new single-dose treatment for P. vivax malaria developed in 70 years, in its public health system. Raquel da Silva has lived in Manaus in Brazil’s Amazonas State since her childhood. Today she shares her home on the banks of the Rio Negro […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Health AI: Geneva Initiative Launches Global Agency to Support Artificial Intelligence Regulation 06/10/2023 Elaine Ruth Fletcher GENEVA – At the 1853 World Fair, the inventor of a new safety brake technology for elevators, Elisha Otis, demonstrated his innovation by posing an elevator right over the heads of a crowd of visitors and then cutting the cables. The new security brake kicked in. His gimmick helped build trust in an innovation that […] Continue reading -> Strengthening Africa’s Medicines Regulatory Framework is ‘Essential’ for Local Vaccine Production 13/09/2023 Kerry Cullinan Strengthening Africa’s medicines regulatory framework is key to achieving the “bold goal” of having 60% of the continent’s vaccines produced locally by 2040, said Margareth Ndomondo-Sigonda, head of health at the African Union’s development agency, AUDA-NEPAD. But only 7% of African country’s national medicines regulatory agencies (NMRA) have “moderately developed capacity”, and more than 90% […] Continue reading -> UN Draft Pandemic Declaration Offers ‘Little Hope’ for Strengthening Global Preparedness 01/09/2023 Stefan Anderson A draft political declaration on pandemics, due to be adopted by the United Nations General Assembly later this month, offers “little hope” that the UN process will make a difference in global pandemic preparedness, global health experts said on Friday. The document, made public on Thursday, is long on words but short on commitments. The […] Continue reading -> WHO Secures First COVID-19 Vaccine Licence from Private Pharmaceutical Company 31/08/2023 Stefan Anderson Three years after the launch of its COVID-19 Technology Access Pool (C-TAP) initiative, the World Health Organization (WHO) has secured its first COVID-19 vaccine license from a private pharmaceutical company, the UN health body announced on Tuesday. The agreement with Medigen Vaccine Biologics Corp., a private vaccine manufacturer based in Taiwan, is a welcome but underwhelming […] Continue reading -> Africa’s Cardiovascular Burden: A Silent Cry for Attention 23/08/2023 Ahmed Bendary & Abdelrahman Abushouk Amidst the vibrant rhythms of Africa, a less audible rhythm beats – an alarming rise in cardiovascular diseases (CVDs) and non-communicable diseases (NCDs). Between 50% and 88% of deaths in at least seven African countries are due to NCDs, according to the 2022 World Health Organization (WHO) Noncommunicable Disease Progress Monitor. Yet, the realm of […] Continue reading -> Brazil’s Success in Preventing Malaria Relapse Using New Single-Dose Treatment 20/07/2023 Marcus Lacerda & Elodie Jambert Brazil is the first country in the world to introduce tafenoquine, the first new single-dose treatment for P. vivax malaria developed in 70 years, in its public health system. Raquel da Silva has lived in Manaus in Brazil’s Amazonas State since her childhood. Today she shares her home on the banks of the Rio Negro […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Strengthening Africa’s Medicines Regulatory Framework is ‘Essential’ for Local Vaccine Production 13/09/2023 Kerry Cullinan Strengthening Africa’s medicines regulatory framework is key to achieving the “bold goal” of having 60% of the continent’s vaccines produced locally by 2040, said Margareth Ndomondo-Sigonda, head of health at the African Union’s development agency, AUDA-NEPAD. But only 7% of African country’s national medicines regulatory agencies (NMRA) have “moderately developed capacity”, and more than 90% […] Continue reading -> UN Draft Pandemic Declaration Offers ‘Little Hope’ for Strengthening Global Preparedness 01/09/2023 Stefan Anderson A draft political declaration on pandemics, due to be adopted by the United Nations General Assembly later this month, offers “little hope” that the UN process will make a difference in global pandemic preparedness, global health experts said on Friday. The document, made public on Thursday, is long on words but short on commitments. The […] Continue reading -> WHO Secures First COVID-19 Vaccine Licence from Private Pharmaceutical Company 31/08/2023 Stefan Anderson Three years after the launch of its COVID-19 Technology Access Pool (C-TAP) initiative, the World Health Organization (WHO) has secured its first COVID-19 vaccine license from a private pharmaceutical company, the UN health body announced on Tuesday. The agreement with Medigen Vaccine Biologics Corp., a private vaccine manufacturer based in Taiwan, is a welcome but underwhelming […] Continue reading -> Africa’s Cardiovascular Burden: A Silent Cry for Attention 23/08/2023 Ahmed Bendary & Abdelrahman Abushouk Amidst the vibrant rhythms of Africa, a less audible rhythm beats – an alarming rise in cardiovascular diseases (CVDs) and non-communicable diseases (NCDs). Between 50% and 88% of deaths in at least seven African countries are due to NCDs, according to the 2022 World Health Organization (WHO) Noncommunicable Disease Progress Monitor. Yet, the realm of […] Continue reading -> Brazil’s Success in Preventing Malaria Relapse Using New Single-Dose Treatment 20/07/2023 Marcus Lacerda & Elodie Jambert Brazil is the first country in the world to introduce tafenoquine, the first new single-dose treatment for P. vivax malaria developed in 70 years, in its public health system. Raquel da Silva has lived in Manaus in Brazil’s Amazonas State since her childhood. Today she shares her home on the banks of the Rio Negro […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
UN Draft Pandemic Declaration Offers ‘Little Hope’ for Strengthening Global Preparedness 01/09/2023 Stefan Anderson A draft political declaration on pandemics, due to be adopted by the United Nations General Assembly later this month, offers “little hope” that the UN process will make a difference in global pandemic preparedness, global health experts said on Friday. The document, made public on Thursday, is long on words but short on commitments. The […] Continue reading -> WHO Secures First COVID-19 Vaccine Licence from Private Pharmaceutical Company 31/08/2023 Stefan Anderson Three years after the launch of its COVID-19 Technology Access Pool (C-TAP) initiative, the World Health Organization (WHO) has secured its first COVID-19 vaccine license from a private pharmaceutical company, the UN health body announced on Tuesday. The agreement with Medigen Vaccine Biologics Corp., a private vaccine manufacturer based in Taiwan, is a welcome but underwhelming […] Continue reading -> Africa’s Cardiovascular Burden: A Silent Cry for Attention 23/08/2023 Ahmed Bendary & Abdelrahman Abushouk Amidst the vibrant rhythms of Africa, a less audible rhythm beats – an alarming rise in cardiovascular diseases (CVDs) and non-communicable diseases (NCDs). Between 50% and 88% of deaths in at least seven African countries are due to NCDs, according to the 2022 World Health Organization (WHO) Noncommunicable Disease Progress Monitor. Yet, the realm of […] Continue reading -> Brazil’s Success in Preventing Malaria Relapse Using New Single-Dose Treatment 20/07/2023 Marcus Lacerda & Elodie Jambert Brazil is the first country in the world to introduce tafenoquine, the first new single-dose treatment for P. vivax malaria developed in 70 years, in its public health system. Raquel da Silva has lived in Manaus in Brazil’s Amazonas State since her childhood. Today she shares her home on the banks of the Rio Negro […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Secures First COVID-19 Vaccine Licence from Private Pharmaceutical Company 31/08/2023 Stefan Anderson Three years after the launch of its COVID-19 Technology Access Pool (C-TAP) initiative, the World Health Organization (WHO) has secured its first COVID-19 vaccine license from a private pharmaceutical company, the UN health body announced on Tuesday. The agreement with Medigen Vaccine Biologics Corp., a private vaccine manufacturer based in Taiwan, is a welcome but underwhelming […] Continue reading -> Africa’s Cardiovascular Burden: A Silent Cry for Attention 23/08/2023 Ahmed Bendary & Abdelrahman Abushouk Amidst the vibrant rhythms of Africa, a less audible rhythm beats – an alarming rise in cardiovascular diseases (CVDs) and non-communicable diseases (NCDs). Between 50% and 88% of deaths in at least seven African countries are due to NCDs, according to the 2022 World Health Organization (WHO) Noncommunicable Disease Progress Monitor. Yet, the realm of […] Continue reading -> Brazil’s Success in Preventing Malaria Relapse Using New Single-Dose Treatment 20/07/2023 Marcus Lacerda & Elodie Jambert Brazil is the first country in the world to introduce tafenoquine, the first new single-dose treatment for P. vivax malaria developed in 70 years, in its public health system. Raquel da Silva has lived in Manaus in Brazil’s Amazonas State since her childhood. Today she shares her home on the banks of the Rio Negro […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Africa’s Cardiovascular Burden: A Silent Cry for Attention 23/08/2023 Ahmed Bendary & Abdelrahman Abushouk Amidst the vibrant rhythms of Africa, a less audible rhythm beats – an alarming rise in cardiovascular diseases (CVDs) and non-communicable diseases (NCDs). Between 50% and 88% of deaths in at least seven African countries are due to NCDs, according to the 2022 World Health Organization (WHO) Noncommunicable Disease Progress Monitor. Yet, the realm of […] Continue reading -> Brazil’s Success in Preventing Malaria Relapse Using New Single-Dose Treatment 20/07/2023 Marcus Lacerda & Elodie Jambert Brazil is the first country in the world to introduce tafenoquine, the first new single-dose treatment for P. vivax malaria developed in 70 years, in its public health system. Raquel da Silva has lived in Manaus in Brazil’s Amazonas State since her childhood. Today she shares her home on the banks of the Rio Negro […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Brazil’s Success in Preventing Malaria Relapse Using New Single-Dose Treatment 20/07/2023 Marcus Lacerda & Elodie Jambert Brazil is the first country in the world to introduce tafenoquine, the first new single-dose treatment for P. vivax malaria developed in 70 years, in its public health system. Raquel da Silva has lived in Manaus in Brazil’s Amazonas State since her childhood. Today she shares her home on the banks of the Rio Negro […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts